Literature DB >> 33581799

PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer.

Thomas A Hope1, Jeremie Calais2.   

Abstract

Entities:  

Year:  2021        PMID: 33581799     DOI: 10.1016/S0140-6736(21)00349-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  [Technical innovations and future perspectives].

Authors:  M Wagner; A Schulze; S Bodenstedt; L Maier-Hein; S Speidel; F Nickel; F Berlth; B P Müller-Stich; Peter Grimminger
Journal:  Chirurg       Date:  2022-01-24       Impact factor: 0.955

Review 2.  Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers.

Authors:  Zhaoguo Han; Mingxing Ke; Xiang Liu; Jing Wang; Zhengqi Guan; Lina Qiao; Zhexi Wu; Yingying Sun; Xilin Sun
Journal:  Mol Imaging Biol       Date:  2021-07-16       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.